eZono develops portable tablet ultrasound systems, notably the eZono 3000, a touch‑screen device with CueCards and downloadable multimedia apps to lower the training barrier for regional anaesthesia and emergency care. The company launched the eZono 3000 in May 2009 and emphasizes usability to broaden ultrasound adoption. It has sold more than 450 eZono 3000 systems in over 30 countries; the device achieved CE mark in May 2009 and FDA 510(k) clearance in July 2011. eZono plans to introduce a novel needle guidance technology in 2013 to simplify needle placement and accelerate adoption of ultrasound‑guided regional anaesthesia. With the new financing, eZono will expand R&D in Jena and invest significantly in its global sales operations. The company reported 60% revenue growth in 2012.

Total raised

$10M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2013